Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Orthofix Medical Inc.NASDAQ: OFIX

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 107.5% from a year ago

Cash & equivalents stood at $120.28M at the end of Q1 FY2026, up 107.5% from a year earlier and up 46.6% from the prior quarter. Over 3 fiscal years it compounded at +17.4% a year.

Context

  • Cash & equivalents amounted to 13.6% of total assets at the end of Q1 FY2026, up 6.5 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +107.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$120.28M+46.6% QoQ
Last fiscal yearDec 2025
$82.03M-1.5% YoY
Year agoMar 2025
$57.95M+107.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.5%——
1 year-1.5%——
3-year CAGR+17.4%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
82.03M USD
Year-over-year change
-1.5%
4-year CAGR
-1.7%

Cash & Equivalents vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's Mar 2026 cash & equivalents of $120.28M is the 5th highest of the 11 companies compared; the peer median is $75.45M.
  • Its year-over-year change of +107.5% is the highest of 11, against a peer median of -14.8%.
  • Cash & equivalents amounts to 13.6% of total assets for OFIX, versus a peer median of 16.7%.
OFIX Competitors Peer median
Cash & Equivalents for OFIX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MLTXMoonLake ImmunotherapeuticsMar 2026$298.49M +9.9%+103.8%74.6%
LABStandard BioTools Inc.Mar 2026$265.77M +76.1%+13.3%41.6%
ESPREsperion Therapeutics, Inc.Mar 2026$156.16M +36.2%+10.4%33.8%
BFLYButterfly Network, Inc.Mar 2026$137.95M -11.1%-2.5%48.2%
OFIXOrthofix Medical Inc.Mar 2026$120.28M +107.5%+17.4%13.6%
VREXVarex Imaging CorporationApr 2026$85.3M -58.4%+17.5%7.8%
AVNSAvanos Medical, Inc.Mar 2026$65.6M -32.4%-11.1%6.2%
PACBPacific Biosciences of California, Inc.Mar 2026$56.29M -3.8%-41.9%7.2%
SIBNSI-BONE, Inc.Mar 2026$33.54M -18.6%+26.8%13.8%
DRIODarioHealth Corp.Mar 2026$20.26M -27.2%-19.0%19.6%
ABSIAbsci CorporationMar 2026$8.63M -81.6%-30.6%4.4%
Peer median (excluding OFIX) $75.45M-14.8%+3.9%16.7%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents87.85M50.7M33.11M83.24M82.03M
Short-term Investments00000
Net Receivables78.56M82.86M128.1M134.71M135.75M
Inventory82.97M100.15M222.17M189.45M34.17M
Other Current Assets022.28M37.07M25.88M164.91M
Total Current Assets269.52M255.99M420.44M433.29M416.85M
Property, Plant & Equipment (Net)59.25M58.23M159.06M139.8M(11.09M)
Goodwill71.32M71.32M194.93M194.93M194.93M
Intangible Assets52.67M47.39M117.49M98.8M72.77M
Long-term Investments00000
Tax Assets1.77M000254.63M
Other Non-current Assets22.1M25.71M33.39M26.47M(77.44M)
Total Non-current Assets207.1M202.64M504.87M460.01M433.8M
Total Assets476.62M458.63M925.32M893.29M850.65M
Account Payables26.46M27.6M58.36M48.8M58.39M
Short-term Debt001.25M03.98M
Tax Payables4.66M6.59M7.59M8.41M0
Deferred Revenue00000
Other Current Liabilities21.99M01M7.1M81.08M
Total Current Liabilities105.83M83.62M165.22M168.63M170.48M
Long-term Debt0093.11M157.02M182.8M
Deferred Tax Liabilities00006.08M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13.97M18.91M49.72M46.69M(1.23M)
Total Non-current Liabilities33.86M38.15M161.36M221.54M230.13M
Total Liabilities139.69M121.77M326.59M390.17M400.61M
Common Stock1.98M2.02M3.72M3.85M3.98M
Retained Earnings21M1.25M(150.14M)(276.14M)(368.33M)
Accumulated OCI0(1.38M)(1.29M)(4.3M)618K
Other Stockholders Equity00000
Minority Interest00000
Total Equity336.93M336.86M598.73M503.12M450.04M
Total Debt24.31M21.53M117.07M179.63M229.26M
Net Debt(63.53M)(29.17M)83.97M96.39M147.24M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.